Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Guus Rimmelzwaan

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Disorders

Chemicals & Drugs

Anatomy

Genes & Molecular Sequences

Amino Acid Sequence

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Bodewes R; Geelhoed-Mieras M M; Heldens J G M; Glover J; Lambrecht B N; Fouchier R A M; Osterhaus A D M E; Rimmelzwaan G F
The novel adjuvant CoVaccineHT increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro.
Rimmelzwaan Guus F; Kreijtz Joost H C M; Bodewes Rogier; Fouchier Ron A M; Osterhaus Albert D M E
Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
Kreijtz J H C M; Suezer Y; de Mutsert G; van den Brand J M A; van Amerongen G; Schnierle B S; Kuiken T; Fouchier R A M; Löwer J; Osterhaus A D M E; Sutter G; Rimmelzwaan G F
Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Guus Rimmelzwaan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Bodewes R; Geelhoed-Mieras M M; Heldens J G M; Glover J; Lambrecht B N; Fouchier R A M; Osterhaus A D M E; Rimmelzwaan G F
The novel adjuvant CoVaccineHT increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro.
Vaccine 2009;27(49):6833-9.
2009: Rimmelzwaan Guus F; Kreijtz Joost H C M; Bodewes Rogier; Fouchier Ron A M; Osterhaus Albert D M E
Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
Vaccine 2009;27(45):6363-5.
2009: Kreijtz J H C M; Suezer Y; de Mutsert G; van den Brand J M A; van Amerongen G; Schnierle B S; Kuiken T; Fouchier R A M; Löwer J; Osterhaus A D M E; Sutter G; Rimmelzwaan G F
Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.
Vaccine 2009;27(45):6296-9.
2009: GeurtsvanKessel Corine H; Willart Monique A M; Bergen Ingrid M; van Rijt Leonie S; Muskens Femke; Elewaut Dirk; Osterhaus Albert D M E; Hendriks Rudi; Rimmelzwaan Guus F; Lambrecht Bart N
Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice.
The Journal of experimental medicine 2009;206(11):2339-49.
2009: de Goede Anna L; Boers Patrick H M; Dekker Lennard J M; Osterhaus Albert D M E; Gruters Rob A; Rimmelzwaan Guus F
Characterization of recombinant influenza A virus as a vector for HIV-1 p17Gag.
Vaccine 2009;27(42):5735-9.
2009: Rygiel Tomasz P; Rijkers Eva S K; de Ruiter Talitha; Stolte Ellen H; van der Valk Martin; Rimmelzwaan Guus F; Boon Louis; van Loon Anton M; Coenjaerts Frank E; Hoek Robert M; Tesselaar Kiki; Meyaard Linde
Lack of CD200 enhances pathological T cell responses during influenza infection.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(3):1990-6.
2009: Kreijtz J H C M; Bodewes R; van den Brand J M A; de Mutsert G; Baas C; van Amerongen G; Fouchier R A M; Osterhaus A D M E; Rimmelzwaan G F
Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.
Vaccine 2009;27(36):4983-9.
2009: Munster Vincent J; de Wit Emmie; van den Brand Judith M A; Herfst Sander; Schrauwen Eefje J A; Bestebroer Theo M; van de Vijver David; Boucher Charles A; Koopmans Marion; Rimmelzwaan Guus F; Kuiken Thijs; Osterhaus Albert D M E; Fouchier Ron A M
Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets.
Science (New York, N.Y.) 2009;325(5939):481-3.
2009: Reperant L A; Rimmelzwaan G F; Kuiken T
Avian influenza viruses in mammals.
Revue scientifique et technique (International Office of Epizootics) 2009;28(1):137-59.
2009: Rimmelzwaan Guus F; Sutter Gerd
Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara.
Expert review of vaccines 2009;8(4):447-54.
2009: Munster Vincent J; Baas Chantal; Lexmond Pascal; Bestebroer Theo M; Guldemeester Judith; Beyer Walter E P; de Wit Emmie; Schutten Martin; Rimmelzwaan Guus F; Osterhaus Albert D M E; Fouchier Ron A M
Practical considerations for high-throughput influenza A virus surveillance studies of wild birds by use of molecular diagnostic tests.
Journal of clinical microbiology 2009;47(3):666-73.
2009: Kreijtz Joost H C M; Osterhaus Albert D M E; Rimmelzwaan Guus F
Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.
Human vaccines 2009;5(3):126-35.
2009: Kreijtz J H C M; Suezer Y; de Mutsert G; van den Brand J M A; van Amerongen G; Schnierle B S; Kuiken T; Fouchier R A M; Löwer J; Osterhaus A D M E; Sutter G; Rimmelzwaan G F
Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.
The Journal of infectious diseases 2009;199(3):405-13.
2009: Huisman W; Martina B E E; Rimmelzwaan G F; Gruters R A; Osterhaus A D M E
Vaccine-induced enhancement of viral infections.
Vaccine 2009;27(4):505-12.
2009: Kreijtz Joost H C M; Suezer Yasemin; de Mutsert Gerrie; van Amerongen Geert; Schwantes Astrid; van den Brand Judith M A; Fouchier Ron A M; Löwer Johannes; Osterhaus Albert D M E; Sutter Gerd; Rimmelzwaan Guus F
MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.
PloS one 2009;4(11):e7790.
2009: GeurtsvanKessel Corine H; Bergen Ingrid M; Muskens Femke; Boon Louis; Hoogsteden Henk C; Osterhaus Albert D M E; Rimmelzwaan Guus F; Lambrecht Bart N
Both conventional and interferon killer dendritic cells have antigen-presenting capacity during influenza virus infection.
PloS one 2009;4(9):e7187.
2009: Bodewes Rogier; Kreijtz Joost H C M; Baas Chantal; Geelhoed-Mieras Martina M; de Mutsert Gerrie; van Amerongen Geert; van den Brand Judith M A; Fouchier Ron A M; Osterhaus Albert D M E; Rimmelzwaan Guus F
Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.
PloS one 2009;4(5):e5538.
2008: Reperant Leslie A; van Amerongen Geert; van de Bildt Marco W G; Rimmelzwaan Guus F; Dobson Andrew P; Osterhaus Albert D M E; Kuiken Thijs
Highly pathogenic avian influenza virus (H5N1) infection in red foxes fed infected bird carcasses.
Emerging infectious diseases 2008;14(12):1835-41.
2008: Huisman Willem; Schrauwen Eefje J A; Tijhaar Edwin; Süzer Yasemin; Pas Suzan D; van Amerongen Geert; Sutter Gerd; Rimmelzwaan Guus F; Osterhaus Albert D M E
Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.
Veterinary immunology and immunopathology 2008;126(3-4):332-8.
2008: van Baalen Carel A; Gruters Rob A; Berkhoff Eufemia G M; Osterhaus Albert D M E; Rimmelzwaan Guus F
FATT-CTL assay for detection of antigen-specific cell-mediated cytotoxicity.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2008;73(11):1058-65.
2008: Huisman Willem; Schrauwen Eefje J A; Rimmelzwaan Guus F; Osterhaus Albert D M E
Intrahost evolution of envelope glycoprotein and OrfA sequences after experimental infection of cats with a molecular clone and a biological isolate of feline immunodeficiency virus.
Virus research 2008;137(1):24-32.
2008: Rimmelzwaan Guus F; McElhaney Janet E
Correlates of protection: novel generations of influenza vaccines.
Vaccine 2008;26 Suppl 4():D41-4.
2008: Russell Colin A; Jones Terry C; Barr Ian G; Cox Nancy J; Garten Rebecca J; Gregory Vicky; Gust Ian D; Hampson Alan W; Hay Alan J; Hurt Aeron C; de Jong Jan C; Kielso Anne; Klimov Alexander I; Kageyama Tsutomu; Komadina Naomi; Lapedes Alan S; Lin Yi P; Mosterin Ana; Obuchi Masatsugu; Odagiri Takato; Osterhaus Albert D M E; Rimmelzwaan Guus F; Shaw Michael W; Skepner Eugene; Stohr Klaus; Tashiro Masato; Fouchier Ron A M; Smith Derek J
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.
Vaccine 2008;26 Suppl 4():D31-4.
2008: de Boer Tjitske; van Dissel Jaap T; Kuijpers Taco W J; Rimmelzwaan Guus F; Kroon Frank P; Ottenhoff Tom H M
Influenza virus vaccination induces interleukin-12/23 receptor beta 1 (IL-12/23R beta 1)-independent production of gamma interferon (IFN-gamma) and humoral immunity in patients with genetic deficiencies in IL-12/23R beta 1 or IFN-gamma receptor I.
Clinical and vaccine immunology : CVI 2008;15(8):1171-5.
2008: GeurtsvanKessel Corine H; Willart Monique A M; van Rijt Leonie S; Muskens Femke; Kool Mirjam; Baas Chantal; Thielemans Kris; Bennett Clare; Clausen Björn E; Hoogsteden Henk C; Osterhaus Albert D M E; Rimmelzwaan Guus F; Lambrecht Bart N
Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells.
The Journal of experimental medicine 2008;205(7):1621-34.
2008: LeBouder Fanny; Morello Eric; Rimmelzwaan Guus F; Bosse Françoise; Péchoux Christine; Delmas Bernard; Riteau Béatrice
Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin.
Journal of virology 2008;82(14):6820-8.
2008: Martina Byron E E; Koraka Penelopie; van den Doel Petra; Rimmelzwaan Guus F; Haagmans Bart L; Osterhaus Albert D M E
DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha.
Virus research 2008;135(1):64-71.
2008: Kreijtz J H C M; de Mutsert G; van Baalen C A; Fouchier R A M; Osterhaus A D M E; Rimmelzwaan G F
Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus.
Journal of virology 2008;82(11):5161-6.
2008: Huisman Willem; Schrauwen Eefje J A; Pas Suzan D; van Amerongen Geert; Rimmelzwaan Guus F; Osterhaus Albert D M E
Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in cats.
Vaccine 2008;26(21):2553-61.
2008: Russell Colin A; Jones Terry C; Barr Ian G; Cox Nancy J; Garten Rebecca J; Gregory Vicky; Gust Ian D; Hampson Alan W; Hay Alan J; Hurt Aeron C; de Jong Jan C; Kelso Anne; Klimov Alexander I; Kageyama Tsutomu; Komadina Naomi; Lapedes Alan S; Lin Yi P; Mosterin Ana; Obuchi Masatsugu; Odagiri Takato; Osterhaus Albert D M E; Rimmelzwaan Guus F; Shaw Michael W; Skepner Eugene; Stohr Klaus; Tashiro Masato; Fouchier Ron A M; Smith Derek J
The global circulation of seasonal influenza A (H3N2) viruses.
Science (New York, N.Y.) 2008;320(5874):340-6.
2008: Martina Byron E; Koraka Penelopie; van den Doel Petra; van Amerongen Geert; Rimmelzwaan Guus F; Osterhaus Albert D M E
Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus.
Vaccine 2008;26(2):153-7.
2008: Keller Tymen T; van der Meer Jelger J; Teeling Peter; van der Sluijs Koen; Idu Mirza M; Rimmelzwaan Guus F; Levi Marcel; van der Wal Allard C; de Boer Onno J
Selective expansion of influenza A virus-specific T cells in symptomatic human carotid artery atherosclerotic plaques.
Stroke; a journal of cerebral circulation 2008;39(1):174-9.
2007: Rimmelzwaan Guus F; Fouchier Ron A M; Osterhaus Albert D M E
Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.
Current opinion in biotechnology 2007;18(6):529-36.
2007: Rimmelzwaan Guus F; Nieuwkoop Nella J; de Mutsert Gerrie; Boon Adrianus C M; Kuiken Thijs; Fouchier Ron A M; Osterhaus Albert D M E
Attachment of infectious influenza A viruses of various subtypes to live mammalian and avian cells as measured by flow cytometry.
Virus research 2007;129(2):175-81.
2007: van Riel Debby; Munster Vincent J; de Wit Emmie; Rimmelzwaan Guus F; Fouchier Ron A M; Osterhaus Albert D M E; Kuiken Thijs
Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals.
The American journal of pathology 2007;171(4):1215-23.
2007: Munster Vincent J; de Wit Emmie; van Riel Debby; Beyer Walter E P; Rimmelzwaan Guus F; Osterhaus Albert D M E; Kuiken Thijs; Fouchier Ron A M
The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses.
The Journal of infectious diseases 2007;196(2):258-65.
2007: Kreijtz Joost H C M; Suezer Yasemin; van Amerongen Geert; de Mutsert Gerrie; Schnierle Barbara S; Wood John M; Kuiken Thijs; Fouchier Ron A M; Lower Johannes; Osterhaus Albert D M E; Sutter Gerd; Rimmelzwaan Guus F
Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.
The Journal of infectious diseases 2007;195(11):1598-606.
2007: Berkhoff Eufemia G M; Geelhoed-Mieras Martina M; Jonges Marcel; Smith Derek J; Fouchier Ron A M; Osterhaus Albert D M E; Rimmelzwaan Guus F
An amino acid substitution in the influenza A virus hemagglutinin associated with escape from recognition by human virus-specific CD4+ T-cells.
Virus research 2007;126(1-2):282-7.
2007: Munster Vincent J; Baas Chantal; Lexmond Pascal; Waldenström Jonas; Wallensten Anders; Fransson Thord; Rimmelzwaan Guus F; Beyer Walter E P; Schutten Martin; Olsen Björn; Osterhaus Albert D M E; Fouchier Ron A M
Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds.
PLoS pathogens 2007;3(5):e61.
2007: Berkhoff E G M; Geelhoed-Mieras M M; Verschuren E J; van Baalen C A; Gruters R A; Fouchier R A M; Osterhaus A D M E; Rimmelzwaan G F
The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro.
Clinical and experimental immunology 2007;148(2):296-306.
2007: de Wit Emmie; Spronken Monique I J; Vervaet Gaby; Rimmelzwaan Guus F; Osterhaus Albert D M E; Fouchier Ron A M
A reverse-genetics system for Influenza A virus using T7 RNA polymerase.
The Journal of general virology 2007;88(Pt 4):1281-7.
2007: de Jong J C; Smith D J; Lapedes A S; Donatelli I; Campitelli L; Barigazzi G; Van Reeth K; Jones T C; Rimmelzwaan G F; Osterhaus A D M E; Fouchier R A M
Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe.
Journal of virology 2007;81(8):4315-22.
2007: Berkhoff E G M; Geelhoed-Mieras M M; Fouchier R A M; Osterhaus A D M E; Rimmelzwaan G F
Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones.
The Journal of general virology 2007;88(Pt 2):530-5.
2007: de Wit Emmie; Bestebroer Theo M; Spronken Monique I J; Rimmelzwaan Guus F; Osterhaus Albert D M E; Fouchier Ron A M
Rapid sequencing of the non-coding regions of influenza A virus.
Journal of virological methods 2007;139(1):85-9.
2007: Kreijtz J H C M; Bodewes R; van Amerongen G; Kuiken T; Fouchier R A M; Osterhaus A D M E; Rimmelzwaan G F
Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.
Vaccine 2007;25(4):612-20.
2006: Berkhoff E G M; de Wit E; Geelhoed-Mieras M M; Boon A C M; Symons J; Fouchier R A M; Osterhaus A D M E; Rimmelzwaan G F
Fitness costs limit escape from cytotoxic T lymphocytes by influenza A viruses.
Vaccine 2006;24(44-46):6594-6.
2006: de Wit Emmie; Spronken Monique I J; Rimmelzwaan Guus F; Osterhaus Albert D M E; Fouchier Ron A M
Evidence for specific packaging of the influenza A virus genome from conditionally defective virus particles lacking a polymerase gene.
Vaccine 2006;24(44-46):6647-50.
2006: Rimmelzwaan G F; de Jong J C; Donker G A; Meijer A; Fouchier R A M; Osterhaus A D M E
[The 2005-2006 influenza season in the Netherlands and the vaccine composition for the 2006-2007 season]
Nederlands tijdschrift voor geneeskunde 2006;150(40):2209-14.
2006: Kieny Marie Paule; Costa Alejandro; Hombach Joachim; Carrasco Peter; Pervikov Yuri; Salisbury David; Greco Michel; Gust Ian; LaForce Marc; Franco-Paredes Carlos; Santos José Ignacio; D'Hondt Eric; Rimmelzwaan Guus; Karron Ruth; Fukuda Keiji
A global pandemic influenza vaccine action plan.
Vaccine 2006;24(40-41):6367-70.
2006: Boon Adrianus C M; de Mutsert Gerrie; Fouchier Ron A M; Osterhaus Albert D M E; Rimmelzwaan Guus F
The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.
Journal of virology 2006;80(12):6024-32.
2006: Kuiken Thijs; Holmes Edward C; McCauley John; Rimmelzwaan Guus F; Williams Catherine S; Grenfell Bryan T
Host species barriers to influenza virus infections.
Science (New York, N.Y.) 2006;312(5772):394-7.
2006: Kuiken Thijs; Fouchier Ron; Rimmelzwaan Guus; Osterhaus Albert; Roeder Peter
Feline friend or potential foe?
Nature 2006;440(7085):741-2.
2006: van Riel Debby; Munster Vincent J; de Wit Emmie; Rimmelzwaan Guus F; Fouchier Ron A M; Osterhaus Ab D M E; Kuiken Thijs
H5N1 Virus Attachment to Lower Respiratory Tract.
Science (New York, N.Y.) 2006;312(5772):399.
2006: Toebes Mireille; Coccoris Miriam; Bins Adriaan; Rodenko Boris; Gomez Raquel; Nieuwkoop Nella J; van de Kasteele Willeke; Rimmelzwaan Guus F; Haanen John B A G; Ovaa Huib; Schumacher Ton N M
Design and use of conditional MHC class I ligands.
Nature medicine 2006;12(2):246-51.
2006: Rimmelzwaan Guus F; van Riel Debby; Baars Marianne; Bestebroer Theo M; van Amerongen Geert; Fouchier Ron A M; Osterhaus Albert D M E; Kuiken Thijs
Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts.
The American journal of pathology 2006;168(1):176-83; quiz 364.
2005: Munster Vincent J; Wallensten Anders; Baas Chantal; Rimmelzwaan Guus F; Schutten Martin; Olsen Björn; Osterhaus Albert D M E; Fouchier Ron A M
Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe.
Emerging infectious diseases 2005;11(10):1545-51.
2005: de Jong J C; Rimmelzwaan G F; Bartelds A I M; Meijer A; Fouchier R A M; Osterhaus A D M E
[The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06]
Nederlands tijdschrift voor geneeskunde 2005;149(42):2355-61.
2005: Boon A C M; de Mutsert G; Fouchier R A M; Osterhaus A D M E; Rimmelzwaan G F
Functional profile of human influenza virus-specific cytotoxic T lymphocyte activity is influenced by interleukin-2 concentration and epitope specificity.
Clinical and experimental immunology 2005;142(1):45-52.
2005: de Wit Emmie; Munster Vincent J; Spronken Monique I J; Bestebroer Theo M; Baas Chantal; Beyer Walter E P; Rimmelzwaan Guus F; Osterhaus Albert D M E; Fouchier Ron A M
Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
Journal of virology 2005;79(19):12401-7.
2005: van Baalen Carel A; Kwa David; Verschuren Esther J; Reedijk Mariska L; Boon Adrianus C M; de Mutsert Gerrie; Rimmelzwaan Guus F; Osterhaus Albert D M E; Gruters Rob A
Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity.
The Journal of infectious diseases 2005;192(7):1183-90.
2005: Berkhoff E G M; de Wit E; Geelhoed-Mieras M M; Boon A C M; Symons J; Fouchier R A M; Osterhaus A D M E; Rimmelzwaan G F
Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.
Journal of virology 2005;79(17):11239-46.
2005: Rimmelzwaan G F; Berkhoff E G M; Nieuwkoop N J; Smith D J; Fouchier R A M; Osterhaus A D M E
Full restoration of viral fitness by multiple compensatory co-mutations in the nucleoprotein of influenza A virus cytotoxic T-lymphocyte escape mutants.
The Journal of general virology 2005;86(Pt 6):1801-5.
2005: Fouchier Ron; Kuiken Thijs; Rimmelzwaan Guus; Osterhaus Albert
Global task force for influenza.
Nature 2005;435(7041):419-20.
2005: Fouchier Ron Am; Rimmelzwaan Guus F; Kuiken Thijs; Osterhaus Albert Dme
Newer respiratory virus infections: human metapneumovirus, avian influenza virus, and human coronaviruses.
Current opinion in infectious diseases 2005;18(2):141-6.
2005: Fouchier Ron A M; Munster Vincent; Wallensten Anders; Bestebroer Theo M; Herfst Sander; Smith Derek; Rimmelzwaan Guus F; Olsen Björn; Osterhaus Albert D M E
Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls.
Journal of virology 2005;79(5):2814-22.
2004: Bueving H J; van der Wouden J C; Raat H; Bernsen R M D; de Jongste J C; van Suijlekom-Smit L W A; Osterhaus A D M E; Rimmelzwaan G F; Mölken M Rutten-van; Thomas S
Influenza vaccination in asthmatic children: effects on quality of life and symptoms.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2004;24(6):925-31.
2004: Bueving Herman J; Bernsen Roos M D; de Jongste Johan C; van Suijlekom-Smit Lisette W A; Rimmelzwaan Guus F; Osterhaus Albert D M E; Rutten-van Mölken Maureen P M H; Thomas Siep; van der Wouden Johannes C
Does influenza vaccination exacerbate asthma in children?
Vaccine 2004;23(1):91-6.
2004: Rimmelzwaan G F; de Jong J C; Bartelds A I M; Wilbrink B; Fouchier R A M; Osterhaus A D M E
[The 2003/2004 influenza season in the Netherlands with a limited epidemic of the virus variant A/Fujian, and the vaccine composition for the 2004/2005 season]
Nederlands tijdschrift voor geneeskunde 2004;148(40):1984-8.
2004: Kuiken Thijs; Rimmelzwaan Guus; van Riel Debby; van Amerongen Geert; Baars Marianne; Fouchier Ron; Osterhaus Albert
Avian H5N1 influenza in cats.
Science (New York, N.Y.) 2004;306(5694):241.
2004: Rimmelzwaan G F; Berkhoff E G M; Nieuwkoop N J; Fouchier R A M; Osterhaus A D M E
Functional compensation of a detrimental amino acid substitution in a cytotoxic-T-lymphocyte epitope of influenza a viruses by comutations.
Journal of virology 2004;78(16):8946-9.
2004: Rimmelzwaan G F; Boon A C M; Geelhoed-Mieras M M; Voeten J T M; Fouchier R A M; Osterhaus A D M E
Human airway epithelial cells present antigen to influenza virus-specific CD8+ CTL inefficiently after incubation with viral protein together with ISCOMATRIX.
Vaccine 2004;22(21-22):2769-75.
2004: Huisman Willem; Schrauwen Eefje J A; Pas Suzan D; Karlas Jos A; Rimmelzwaan Guus F; Osterhaus Albert D M E
Antibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in cats.
The Journal of general virology 2004;85(Pt 7):1833-41.
2004: Smith Derek J; Lapedes Alan S; de Jong Jan C; Bestebroer Theo M; Rimmelzwaan Guus F; Osterhaus Albert D M E; Fouchier Ron A M
Mapping the antigenic and genetic evolution of influenza virus.
Science (New York, N.Y.) 2004;305(5682):371-6.
2004: de Wit Emmie; Spronken Monique I J; Bestebroer Theo M; Rimmelzwaan Guus F; Osterhaus Albert D M E; Fouchier Ron A M
Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments.
Virus research 2004;103(1-2):155-61.
2004: Rimmelzwaan G F; Boon A C M; Voeten J T M; Berkhoff E G M; Fouchier R A M; Osterhaus A D M E
Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
Virus research 2004;103(1-2):97-100.
2004: Berkhoff E G M; Boon A C M; Nieuwkoop N J; Fouchier R A M; Sintnicolaas K; Osterhaus A D M E; Rimmelzwaan G F
A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro.
Journal of virology 2004;78(10):5216-22.
2004: Boon Adrianus C M; De Mutsert Gerrie; Fouchier Ron A M; Sintnicolaas Kees; Osterhaus Albert D M E; Rimmelzwaan Guus F
Preferential HLA usage in the influenza virus-specific CTL response.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(7):4435-43.
2004: Boon A C M; Plotkin S; Rimmelzwaan G F; Osterhaus A D M E
Viral vaccine meeting held in Barcelona, October 25-28, 2003.
Vaccine 2004;22(11-12):1327-34.
2004: Haagmans Bart L; Kuiken Thijs; Martina Byron E; Fouchier Ron A M; Rimmelzwaan Guus F; van Amerongen Geert; van Riel Debby; de Jong Ton; Itamura Shigeyuki; Chan Kwok-Hung; Tashiro Masato; Osterhaus Albert D M E
Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.
Nature medicine 2004;10(3):290-3.
2004: Boon Adrianus C M; de Mutsert Gerrie; van Baarle Debbie; Smith Derek J; Lapedes Alan S; Fouchier Ron A M; Sintnicolaas Kees; Osterhaus Albert D M E; Rimmelzwaan Guus F
Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(4):2453-60.
2004: Fouchier Ron A M; Schneeberger Peter M; Rozendaal Frans W; Broekman Jan M; Kemink Stiena A G; Munster Vincent; Kuiken Thijs; Rimmelzwaan Guus F; Schutten Martin; Van Doornum Gerard J J; Koch Guus; Bosman Arnold; Koopmans Marion; Osterhaus Albert D M E
Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(5):1356-61.
2004: Bueving Herman J; Bernsen Roos M D; de Jongste Johan C; van Suijlekom-Smit Lisette W A; Rimmelzwaan Guus F; Osterhaus Albert D M E; Rutten-van Mölken Maureen P M H; Thomas Siep; van der Wouden Johannes C
Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial.
American journal of respiratory and critical care medicine 2004;169(4):488-93.
2004: de Jong J C; Beyer W E; Rimmelzwaan G F; Fouchier R A; Osterhaus A D
[Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza]
Nederlands tijdschrift voor geneeskunde 2004;148(2):73-9.
2003: Kuiken Thijs; Fouchier Ron; Rimmelzwaan Guus; Osterhaus Albert
Emerging viral infections in a rapidly changing world.
Current opinion in biotechnology 2003;14(6):641-6.
2003: Martina Byron E E; Haagmans Bart L; Kuiken Thijs; Fouchier Ron A M; Rimmelzwaan Guus F; Van Amerongen Geert; Peiris J S Malik; Lim Wilina; Osterhaus Albert D M E
Virology: SARS virus infection of cats and ferrets.
Nature 2003;425(6961):915.
2003: de Jong J C; Rimmelzwaan G F; Bartelds A I; Wilbrink B; Fouchier R A; Osterhaus A D
[The 2002/2003 influenza season in the Netherlands and the vaccine composition for the 2003/2004 season]
Nederlands tijdschrift voor geneeskunde 2003;147(40):1971-5.
2003: Gog Julia R; Rimmelzwaan Guus F; Osterhaus Albert D M E; Grenfell Bryan T
Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(19):11143-7.
2003: Kuiken Thijs; Fouchier Ron A M; Schutten Martin; Rimmelzwaan Guus F; van Amerongen Geert; van Riel Debby; Laman Jon D; de Jong Ton; van Doornum Gerard; Lim Wilina; Ling Ai Ee; Chan Paul K S; Tam John S; Zambon Maria C; Gopal Robin; Drosten Christian; van der Werf Sylvie; Escriou Nicolas; Manuguerra Jean-Claude; Stöhr Klaus; Peiris J S Malik; Osterhaus Albert D M E
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.
Lancet 2003;362(9380):263-70.
2003: Kuiken T; Rimmelzwaan G F; Van Amerongen G; Osterhaus A D M E
Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis).
Veterinary pathology 2003;40(3):304-10.
2003: de Jong J C; Palache A M; Beyer W E P; Rimmelzwaan G F; Boon A C M; Osterhaus A D M E
Haemagglutination-inhibiting antibody to influenza virus.
Developments in biologicals 2003;115():63-73.
2003: Rimmelzwaan G F; Kuiken T; van Amerongen G; Bestebroer T M; Fouchier R A M; Osterhaus A D M E
A primate model to study the pathogenesis of influenza A (H5N1) virus infection.
Avian diseases 2003;47(3 Suppl):931-3.
2003: Fouchier R A M; Olsen B; Bestebroer T M; Herfst S; van der Kemp L; Rimmelzwaan G F; Osterhaus A D M E
Influenza A virus surveillance in wild birds in Northern Europe in 1999 and 2000.
Avian diseases 2003;47(3 Suppl):857-60.
2002: Rimmelzwaan G F; de Jong J C; Bartelds A I M; Wilbrink B; Fouchier R A M; Osterhaus A D M E
[The 2001/2002 influenza season and the vaccine composition for the 2002/2003 season]
Nederlands tijdschrift voor geneeskunde 2002;146(39):1846-50.
2002: Wouters-Wesseling Wendeline; Rozendaal Marja; Snijder Marieke; Graus Yvo; Rimmelzwaan Guus; De Groot Lisette; Bindels Jacques
Effect of a complete nutritional supplement on antibody response to influenza vaccine in elderly people.
The journals of gerontology. Series A, Biological sciences and medical sciences 2002;57(9):M563-6.
2002: Boon A C M; Fringuelli E; Graus Y M F; Fouchier R A M; Sintnicolaas K; Iorio A M; Rimmelzwaan G F; Osterhaus A D M E
Influenza A virus specific T cell immunity in humans during aging.
Virology 2002;299(1):100-8.
2002: Osterhaus A D M E; de Jong J C; Rimmelzwaan G F; Claas E C J
H5N1 influenza in Hong Kong: virus characterizations.
Vaccine 2002;20 Suppl 2():S82-3.
2002: Ljungberg Karl; Kolmskog Camilla; Wahren Britta; van Amerongen Geert; Baars Marianne; Osterhaus Albert; Linde Annika; Rimmelzwaan Guus
DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes.
Vaccine 2002;20(16):2045-52.
2002: Boon A C M; de Mutsert G; Graus Y M F; Fouchier R A M; Sintnicolaas K; Osterhaus A D M E; Rimmelzwaan G F
Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
Journal of virology 2002;76(5):2567-72.
2002: Boon A C M; Vos A P; Graus Y M F; Rimmelzwaan G F; Osterhaus A D M E
In vitro effect of bioactive compounds on influenza virus specific B- and T-cell responses.
Scandinavian journal of immunology 2002;55(1):24-32.
2002: Boon A C M; de Mutsert G; Graus Y M F; Fouchier R A M; Sintnicolaas K; Osterhaus A D M E; Rimmelzwaan G F
The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.
Journal of virology 2002;76(2):582-90.
2001: de Jong J C; Rimmelzwaan G F; Bartelds A I; Wilbrink B; Fouchier R A; Osterhaus A D
[2000/01 influenza season and the vaccine composition for the season 2001/'02]
Nederlands tijdschrift voor geneeskunde 2001;145(40):1945-50.
2001: Rimmelzwaan G F; Baars M; van Amerongen G; van Beek R; Osterhaus A D
A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses.
Vaccine 2001;20(1-2):158-63.
2001: Voeten J T; Rimmelzwaan G F; Nieuwkoop N J; Fouchier R A; Osterhaus A D
Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells.
Clinical and experimental immunology 2001;125(3):423-31.
2001: de Jong J C; Heinen P P; Loeffen W L; van Nieuwstadt A P; Claas E C; Bestebroer T M; Bijlsma K; Verweij C; Osterhaus A D; Rimmelzwaan G F; Fouchier R A; Kimman T G
Antigenic and molecular heterogeneity in recent swine influenza A(H1N1) virus isolates with possible implications for vaccination policy.
Vaccine 2001;19(31):4452-64.
2001: Rimmelzwaan G F; Kuiken T; van Amerongen G; Bestebroer T M; Fouchier R A; Osterhaus A D
Pathogenesis of influenza A (H5N1) virus infection in a primate model.
Journal of virology 2001;75(14):6687-91.
2001: Rimmelzwaan G F; de Jong J C; Bestebroer T M; van Loon A M; Claas E C; Fouchier R A; Osterhaus A D
Antigenic and genetic characterization of swine influenza A (H1N1) viruses isolated from pneumonia patients in The Netherlands.
Virology 2001;282(2):301-6.
2000: Rimmelzwaan G F; Nieuwkoop N; Brandenburg A; Sutter G; Beyer W E; Maher D; Bates J; Osterhaus A D
A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines.
Vaccine 2000;19(9-10):1180-7.
2000: Fouchier R A; Bestebroer T M; Herfst S; Van Der Kemp L; Rimmelzwaan G F; Osterhaus A D
Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene.
Journal of clinical microbiology 2000;38(11):4096-101.
2000: Voeten J T; Rimmelzwaan G F; Nieuwkoop N J; Lövgren-Bengtsson K; Osterhaus A D
Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activation of specific CD8(+) cytotoxic T lymphocytes.
Vaccine 2000;19(4-5):514-22.
2000: Voeten J T; Bestebroer T M; Nieuwkoop N J; Fouchier R A; Osterhaus A D; Rimmelzwaan G F
Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.
Journal of virology 2000;74(15):6800-7.
2000: De Jong J C; Rimmelzwaan G F; Fouchier R A; Osterhaus A D
Influenza virus: a master of metamorphosis.
The Journal of infection 2000;40(3):218-28.
2000: Osterhaus A D; Rimmelzwaan G F; Martina B E; Bestebroer T M; Fouchier R A
Influenza B virus in seals.
Science (New York, N.Y.) 2000;288(5468):1051-3.
2000: de Jong J C; Beyer W E; Palache A M; Rimmelzwaan G F; Osterhaus A D
Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly.
Journal of medical virology 2000;61(1):94-9.
2000: Soesman N M; Rimmelzwaan G F; Nieuwkoop N J; Beyer W E; Tilanus H W; Kemmeren M H; Metselaar H J; de Man R A; Osterhaus A D
Efficacy of influenza vaccination in adult liver transplant recipients.
Journal of medical virology 2000;61(1):85-93.
1999: Rimmelzwaan G F; Baars M M; de Lijster P; Fouchier R A; Osterhaus A D
Inhibition of influenza virus replication by nitric oxide.
Journal of virology 1999;73(10):8880-3.
1999: Rimmelzwaan G F; Baars M; van Beek R; de Lijster P; de Jong J C; Claas E C; Osterhaus A D
Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine.
Vaccine 1999;17(20-21):2512-6.
1999: Voeten J T; Brands R; Palache A M; van Scharrenburg G J; Rimmelzwaan G F; Osterhaus A D; Claas E C
Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium.
Vaccine 1999;17(15-16):1942-50.
1999: Rimmelzwaan G F; Claas E C; van Amerongen G; de Jong J C; Osterhaus A D
ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus.
Vaccine 1999;17(11-12):1355-8.
1999: Karlas J A; Siebelink K H; Peer M A; Huisman W; Cuisinier A M; Rimmelzwaan G F; Osterhaus A D
Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection.
The Journal of general virology 1999;80 ( Pt 3)():761-5.
1999: Voeten J T; Claas E C; Brands R; Palache A M; van Scharrenburg G J; Rimmelzwaan G F; Osterhaus A D
Generation and characterization of reassortant influenza A viruses propagated in serum-free cultured MDCK-SF1 cells.
Developments in biological standardization 1999;98():77-87; discussion 89-90.
1998: Voeten J T; Groen J; van Alphen D; Claas E C; de Groot R; Osterhaus A D; Rimmelzwaan G F
Use of recombinant nucleoproteins in enzyme-linked immunosorbent assays for detection of virus-specific immunoglobulin A (IgA) and IgG antibodies in influenza virus A- or B-infected patients.
Journal of clinical microbiology 1998;36(12):3527-31.
1998: Karlas J A; Siebelink K H; v Peer M A; Huisman W; Rimmelzwaan G F; Osterhaus A D
Accelerated viraemia in cats vaccinated with fixed autologous FIV-infected cells.
Veterinary immunology and immunopathology 1998;65(2-4):353-65.
1998: Rimmelzwaan G F; Baars M; Claas E C; Osterhaus A D
Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro.
Journal of virological methods 1998;74(1):57-66.
1998: Claas E C; de Jong J C; van Beek R; Rimmelzwaan G F; Osterhaus A D
Human influenza virus A/HongKong/156/97 (H5N1) infection.
Vaccine 1998;16(9-10):977-8.
1998: Claas E C; Osterhaus A D; van Beek R; De Jong J C; Rimmelzwaan G F; Senne D A; Krauss S; Shortridge K F; Webster R G
Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus.
Lancet 1998;351(9101):472-7.
1998: Huisman W; Karlas J A; Siebelink K H; Huisman R C; de Ronde A; Francis M J; Rimmelzwaan G F; Osterhaus A D
Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection.
Vaccine 1998;16(2-3):181-7.
1998: Osterhaus A D; Rimmelzwaan G F
Induction of virus-specific immunity by iscoms.
Developments in biological standardization 1998;92():49-58.
1997: Rimmelzwaan G F; Baars M; van Beek R; van Amerongen G; Lövgren-Bengtsson K; Claas E C; Osterhaus A D
Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines.
The Journal of general virology 1997;78 ( Pt 4)():757-65.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Guus Rimmelzwaan

Research Profile (preview)

Living Beings

Disorders

Chemicals & Drugs

Anatomy

Genes & Molecular Sequences

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Guus Rimmelzwaan (preview)

All Publications